medicare
Explore all Articles
filter by–Region
filter by–Country
search by–Keyword
Medicare Part B as in Biologic: A Descriptive Analysis of Medicare Part B Drug Spending and Policy Analysis Over the Last Decade
03.3.24
Without focused reform, Medicare Part B drug spending will continue to grow at a faster rate than any other section in Medicare.
Business and Regulation
Making The Cut: The Ramifications of Drug Pricing Reform in the U.S.
05.4.22
Astronomically high drug prices are not a new issue in the wild world that is United States healthcare. The U.S. tends to spend far more on the same prescription medications than most of the world, and this has significant impacts on patients’ health and financial outcomes. Forty percent of patients attribute difficulty affording medications as […]